TGen News & Press Releases : Cancer caregivers recognized as first responders in the home
  • Posted Monday November 20, 2017

Cancer caregivers recognized as first responders in the home

TGen supports Arizona Myeloma Network efforts to share knowledge with cancer caregivers, minimizing their stress and improving patient outcomes

SCOTTSDALE, Ariz. – Nov. 20, 2017 — This year, nearly 38,000 residents of Arizona will be diagnosed with some type of cancer. Each of these cases, on average, will affect at least three others, including family, friends and employers.

The first person to fulfill patient needs often is a caregiver in the home. But often these caregivers are not prepared for such a sudden and crucial role.

To better assist caregivers, the Arizona Myeloma Network (AzMN), with the support of the Translational Genomics Research Institute (TGen), is planning a morning-long gathering, “Cancer is a Family Affair,” from 8:30-11:30 a.m. Dec. 2 at the Embassy Suites by Hilton, 5001 N. Scottsdale Road.

This is another in a series of events organized under AzMN’s Cancer Caregivers Education Program. The event is free, and includes a continental breakfast.

“When cancer enters the home, everyone is suddenly a cancer caregiver. That is why our Cancer Caregivers Education Program is so important,” said Barbara Kavanagh, President and CEO of AzMN. “Everyone caring for a cancer patient should attend.”

As one recent participant said during another AzMN Cancer Caregiver Education Program, “I really appreciate being here. Rarely do I get asked, ‘How are you doing?’ People just don’t know how to help me.”

Tess Burleson, TGen COO, said, “TGen is happy to support the outreach efforts of AzMN. TGen faculty and staff are eager to support this important educational experience provided by AZMN. The cancer caregiver is the cornerstone of patient care in the home.”

Cancer caregivers are encouraged to register for the upcoming Dec. 2 event at

“All our Cancer Caregiver Education Program seminars are provided to the public for free,” said Kavanagh, who encourages others to volunteer, sponsor and donate to AzMN. “It is great that TGen, a longtime supporter, is joining us in the community to educate the cancer caregiver. Cancer unfortunately impacts everyone not just the patient!”

# # #

About TGen
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with neurological disorders, cancer, diabetes, and infectious diseases, through cutting edge translational research (the process of rapidly moving research towards patient benefit).  TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. TGen is affiliated with City of Hope, a world-renowned independent research and cancer and diabetes treatment center: This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. For more information, visit: Follow TGen on FacebookLinkedIn and Twitter @TGen.

Media Contact:
Steve Yozwiak
TGen Senior Science Writer
[email protected]

About AzMN
Founded by Barbara Kavanagh in 2004, the Arizona Myeloma Network (AzMN) is a 501c(3) non-profit FIN 32-0169742. Its mission is to promote education, awareness and advocacy for the improved treatment and quality of life for multiple myeloma and all cancer patients, cancer caregivers and their families. For more information on free cancer education programs visit or email [email protected]

Media Contact:
Barbara Kavanagh, M.S.W.
Founder & CEO, Arizona Myeloma Network
[email protected]

Media Contact

RSS Feed